Join now & save up to 80% on medication

JOIN NOW
Select Language:

Join now and save 80% on medication

Register/Login

Trulicity Dosage

Share Post:

Trulicity Dosage

The recommended dose for individuals starting treatment with Trulicity is 0.75 mg injected (subcutaneously) under the skin in the arm, thigh, or abdomen once a week, preferably on the same time and day per week.

This dose may be increased in 1.5mg increments to facilitate better glycemic control, provided that patients remain on a 3mg weekly dosing for at least four weeks before increasing it to 4.5mg a week.

The 4.5mg dose once a week is the maximum dose a patient should be prescribed for with Trulicity.

Disclaimer: Please note that the contents of this community article are strictly for informational purposes and should not be considered as medical advice. This article, and other community articles, are not written or reviewed for medical validity by Canadian Insulin or its staff. All views and opinions expressed by the contributing authors are not endorsed by Canadian Insulin. Always consult a medical professional for medical advice, diagnosis, and treatment.

Profile image of CDI Staff Writer

Written by CDI Staff WriterOur internal team are experts in many subjects. on January 21, 2021

Related Products

Popular
Trulicity
  • In Stock
  • Express Shipping

Related Articles

Cardiovascular Health, Diabetes,
New Data Proving Metformin is Healthy for the Heart in People with Type 2 Diabetes

Type 2 diabetes mellitus (T2DM) affects millions of people worldwide and significantly increases the risk of heart disease. While managing blood sugar levels is crucial, recent research suggests that some…

Read More
Diabetes, Diabetes Supplies,
Pioglitazone: A Promising Ally Against Sepsis in Type 2 Diabetes Patients

Understanding Sepsis and Its Impact on Diabetic PatientsSepsis is a life-threatening condition that arises when the body’s response to infection causes injury to its own tissues and organs. It’s a…

Read More
Cardiovascular Health, Diabetes,
Pioglitazone: Beneficial for Everything Including Heart Failure?

Pioglitazone is a medication that has been used since 1985 to manage type 2 diabetes mellitus (T2DM). As an insulin sensitizer in the thiazolidinedione (TZD) class, it helps control blood…

Read More
Cancer, Diabetes, Type
GLP-1 Receptor Agonists: A Promising Avenue for Reducing Liver Cancer Risk in Type 2 Diabetes Patients

Hepatocellular carcinoma (HCC) stands as one of the most lethal cancers worldwide, with rising incidence rates paralleling the global increase in obesity, type 2 diabetes, and nonalcoholic fatty liver disease…

Read More